CD70-targeted CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD70-targeted CAR-T cell therapy, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers [Phase 1, Phase 2]